The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Clinical Implications of Basic Research
PreviousPrevious
Volume 355:513-515 August 3, 2006 Number 5
NextNext

Limiting Myocardial Damage during Acute Myocardial Infarction by Inhibiting C-Reactive Protein
Richard N. Kitsis, M.D., and Ishwarlal Jialal, M.D., Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Approximately 1.1 million Americans have an acute myocardial infarction each year. The size of the infarction is a major determinant of both the risk of death and the likelihood of subsequent heart failure. For this reason, a goal of therapy is to reduce the size of the infarct. Current treatments focus on restoration of coronary blood flow (through reperfusion) and reduction of myocardial oxygen demand (e.g., through the use of beta-blockers). Research during the past two decades, however, has tried to elucidate the critical steps in the injury and subsequent killing of myocardial cells, with the hope that antagonizing these . . . [Full Text of this Article]


Source Information

From the Departments of Medicine and Cell Biology, Cardiovascular Research Center and Cancer Center, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, N.Y. (R.N.K.); and the Departments of Pathology and Medicine, University of California, Davis, Davis (I.J.).


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.